Dose-response study of propofol combined with two different doses of esketamine for laryngeal mask airway insertion in women undergoing hysteroscopy.

Objective: To prospectively determine the median effective dose (ED50) of propofol for inhibiting a response to laryngeal mask airway (LMA) insertion when combined with different doses of esketamine in female patients. Methods: A total of 58 female patients (aged 20-60 years, ASAⅠ-Ⅱ) scheduled for elective hysteroscopy were enrolled and randomly divided into 2 groups, one of which was administered 0.2 mg/kg of esketamine (K1 group, n = 28) and the other 0.3 mg/kg of esketamine (K2 group, n = 30). The 2 groups received the corresponding doses of esketamine intravenously, followed by an intravenous injection of propofol (injection time was 30 s). The initial dose of propofol was 2 mg/kg, and the dose ratio of propofol in the adjacent patients was 0.9. If a positive reaction occurred due to LMA insertion, the dose ratio in the next patient was increased by 1 gradient; if not, the dose ratio was decreased by 1 gradient. The ED50, 95 % effective dose (ED95) and 95 % confidence interval (CI) of propofol for inhibiting a response to LMA insertion in the 2 esketamine groups were calculated using probit analysis. Results: The ED50 of propofol for inhibiting a response to LMA insertion in female patients was 1.95 mg/kg (95 % CI, 1.82-2.08 mg/kg) in the K1 group and 1.60 mg/kg (95 % CI, 1.18-1.83 mg/kg) in the K2 group. The ED95 of propofol for inhibiting a response to LMA insertion in female patients was 2.22 mg/kg (95 % CI, 2.09-2.86 mg/kg) in the K1 group and 2.15 mg/kg (95 % CI, 1.88-3.09 mg/kg) in the K2 group. Conclusion: Propofol combined with 0.3 mg/kg of esketamine has low ED50 and ED95 effective doses for inhibiting an LMA insertion response in female patients undergoing hysteroscopy and surgery. There were no significant adverse effects, but the additional dose of propofol and airway pressure were significantly higher than those in the group administered 0.2 mg/kg of esketamine. Based on the results, we recommend the combination of propofol with 0.2 mg/kg esketamine for optimal conditions during LMA insertion in women undergoing hysteroscopy.

[Aluminum-tolerant characteristics of different Chamaecrista genotypes].

A hydroponic culture experiment was conducted to study the responses of 40 Chamaecrista varieties (lines) to 120 mg x L(-1) of Al3+, with the correlations between the relative tolerance values of various characters of different genotypes and the comprehensive evaluation coefficient compared. Among the characters of the genotypes, the relative plant height, relative root dry mass, relative shoot dry mass, and relative root activity could be selected as the important indices for screening the Al-tolerant genotype of Chamaecrista. In the test 40 Chamaecrista varieties (lines), the 86134R2, 2208, 3170, 316, 2211, and 2232 had stronger Al-tolerant capability, belonging to Al-tolerant genotype, whereas the 34721R1, 92985, and 3184 had weaker Al-tolerant capacity, belonging to Al-sensitive genotype.

Structural and photoluminescent studies of lanthanide complexes with tripodal triRNTB (N-substituted tris(benzimidazol-2-ylmethyl)amine): ligand substituent, anionic and secondary ligand effects.

Six N-substituted NTB ligands (NTB = (tris(benzimidazol-2-ylmethyl)amine), namely, triMeNTB (L1), triEtNTB (L2), triPrNTB (L3), triBuNTB (L4), triAlNTB (L5) and triBzNTB (L6), have been synthesized through replacing the H atoms on the NH groups by methyl, ethyl, (n)propyl, (n)butyl, allyl, and benzyl groups, respectively. Their corresponding Sm(3+), Eu(3+) and Tb(3+) complexes consisting of different anions or secondary ligands have been prepared and characterized by elemental analyses, IR spectra and single-crystal X-ray diffraction measurements. Three types of structural models have been obtained: (2) where two triTNTB ligands wrap around the Ln(3+) ion with anions (ClO(4)(-) and CF(3)SO(3)(-)) free of coordination, (3) where one triRNTB ligand holds the Ln(3+) ion with anions (Cl(-), NO(3)(-) and picrate) participating in coordination, and '(3) where one triNTB ligand and three secondary antipyrine ligands coordinate with the Ln(3+) ion. The Ln(3+) ions in (2) type complexes are 8-coordinating and display a slightly distorted cubic (LnN(8)) coordination geometry. The Ln(3+) ions in (3) and '(3) types complexes show two different coordination geometries: one is 7-coordinating ((3) with Cl(-) anion and '(3)), which can be described as a severely distorted cube short of one corner (LnN(4)Cl(3) or LnN(4)O(3)), and the other is 10-coordinating ((3) with NO(3)(-) and picrate anions) which can be regarded as a severely distorted cube with one corner substituted by a three-atom cap (LnN(4)O(6)). The photoluminescent study reveals that the complexes with different Ln(3+) ions show a general luminescent intensity tendency of Tb > Eu > Sm. The modification of the NTB molecule by altering R groups tunes the triplet states of the ligands and results in differentiable photophysical properties of the complexes. The anions or secondary ligand also have remarkable effects on the luminescent properties of the complexes.

Tris(1H-benzimidazol-2-ylmethyl)amine-solvent adducts.

The tris(1H-benzimidazol-2-ylmethyl)amine (ntb) molecule crystallizes in different solvent systems, resulting in two kinds of adduct, namely the monohydrate, C24H21N7.H2O or ntb.H2O, (I), and the acetonitrile-methanol-water (1/0.5/1.5) solvate, C24H21N7.C2H3N.0.5CH4O.1.5H2O or ntb.1.5H2O.0.5MeOH.MeCN, (II). In both cases, ntb adopts a tripodal mode to form hydrogen bonds with a solvent water molecule via two N-H...O and one O-H...N hydrogen bond. In (I), the ntb.H2O adduct is further assembled into a two-dimensional network by N-H...N and O-H...N hydrogen bonds, while in (II), a double-stranded one-dimensional chain structure is assembled via N-H...O and O-H...O hydrogen bonds, with the acetonitrile molecules located inside the cavities of the chain structure.